🔥Telegram İfşa

Turns out u can blur your work/life boundary even further by making your own super niche CAH cards to play with your cohort

Alright Twitter, here's your #BestImmuneCell bracket! Innate cells. Adaptive cells. Each of them have unique benefits to our health. But which one is the "best"?🏆 You vote. Winners advance every 24 hrs Round 1 tips off on March 22🗓️ #Immunology #AcademicTwitter #MarchMadness

*Ginkgo

That aged like a fine wine Pfizer Inc. #sold

The Nobel Prize in Physiology or Medicine 2021 was awarded to David Julius and Ardem Patapoutian "for their discoveries of receptors for temperature and touch". Our own Department Director, Michael J. Caterina, then a postdoc in the Julius lab... 1/5

Happy to share our lab's first manuscript. In work led by Johanna Theruvath, we tested a combo of FDA approved anti-GD2 with blockade of CD47, a macrophage checkpoint. Blocking CD47 unleashes patients' macrophages to phagocytose or 'eat' cancer cells. Combo was highly effective! 1/

Check out our new paper nature: "Clonally Expanded B Cells in Multiple Sclerosis Bind EBV EBNA1 and GlialCAM" - a mechanistic study how molecular mimicry between EBV EBNA1 and the glial cellular adhesion molecule GlialCAM contributes to neuroinflammation. nature.com/articles/s4158…

BREAKING NEWS: The 2022 #NobelPrize in Physiology or Medicine has been awarded to Svante Pääbo “for his discoveries concerning the genomes of extinct hominins and human evolution.”

Congratulations Carolyn Bertozzi!!

Here’s the Atlas Venture 2022 Year In Review. This year, given the 2+ year rollercoaster in the mkts, we start with a deep dive into both the public and private #biotech capital markets, then to the industry overall, closing with an update on ⁦Atlas youtu.be/LONM9ekseJ4

Authored by Andrew G. Soerens et al, we show that #Tcells are capable of proliferating in response to iterative stimulation for over 10yrs! And produce enough progeny to occupy a volume 30,000x the Earth's volume! nature nature.com/articles/s4158…

After a long day of clinic, #ChatGPT helped me write✍️ a letter of medical necessity to an insurance company.😅 🤗🤖 OpenAI ✅👍🏾 #Cancer #Doctor #PatientCare #MedTwitter

Happy to share the newest paper from our lab. Led by technician extraordinaire Aidan Tousley (soon to be an MD/PHD student!), this manuscript details our attempts to reimagine the structure of CARs to improve their specificity and efficacy. rdcu.be/c7avS

Nice piece on exciting new work from CochranLab Stanford Engineering, structure of immune therapy target LAG-3 bound to agonist antibody showing importance of disrupting dimer interface, just published PNASNews news.stanford.edu/2024/03/11/pro…

Recruitment! We are looking for a candidate for the lab (postdoc or scientist) with experience in yeast and/or phage display to work on some cool bioengineering projects for immunotherapy development! Please reach out if interested! Science friends, please retweet!

I am excited to share our Nature Communications paper describing the structure of #LAG3 bound to MHC-II. This project was carried out by Q&M et al at Moffitt Research and provides new insights into the mechanism by which LAG3 suppresses T cell activation. nature.com/articles/s4146…